Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prospective randomized crossover comparison of non-invasive ventilation with Air/O2 vs Heliox21
2009-009599-11Phase 4Terminated
- Sponsor
- Joint Research Office
- Start
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of heliox21 in respiratory failure (2 arms), sponsored by Joint Research Office. Primary endpoints: Breathing rate to tidal volume ratio (f/VT) at 4 hours and Breathing rate to tidal volume ratio (f/VT) at 8 hours. Started Dec 2010; status: terminated.
02
Drugs
heliox21
03
Conditions
respiratory failure
Beyond the preview
Go deeper on 2009-009599-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-009599-11.